|
Market Cap (5-Jun) $4,960,185 (1,007th) |
Close (30-Jun) $0.038 |
Volume (30-Jun) 1,963,571 |
Shortsold (11-May) 1 (0.00%) (717th) |
|
52w High $0.60 |
52w Low $0.083 |
P/E - |
EPS -0.84 |
CHM released this announcement to the ASX on 18 March 2021, 9:14. The announcement is not marked as price sensitive, and is 20 page(s) in length and 3.03MB in size.
You can view all announcements from CHM and see how they appear on a price chart on the announcements page.
At the date of this announcement, CHM was 0.022% short sold according to ASIC data. It was ranked the 533rd most shorted stock on the ASX. It remains ranked 717th as of the latest reported data (11 May 2026).
| Other Recent Announcements from CHM | |
|---|---|
| Notice under section 708A | 29 June 2023, 15:34 |
| Application for quotation of securities - CHM | 29 June 2023, 15:29 |
| Results of Extraordinary General Meeting | 29 June 2023, 11:42 |
| Investor Presentation | 18 March 2021, 9:14 |
| Successful Completion of Dosing in First Patient Cohort | 18 March 2021, 9:04 |
| Chimeric to Present at NWR Virtual Investor Conference | 17 March 2021, 10:28 |
| Change of Director's Interest Notice - CE | 10 March 2021, 11:10 |
You must be logged in to post a reply.
Chimeric Therapeutics Ltd 